Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatic Antifibrotic Pharmacotherapy: Are We Approaching Success?
Yue Chang, Li Hai
Journal of Clinical and Translational Hepatology (2020) Vol. 8, Iss. 2, pp. 222-229
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?
Arshi Khanam, Paul Saleeb, Shyam Kottilil
Cells (2021) Vol. 10, Iss. 5, pp. 1097-1097
Open Access | Times Cited: 81
Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis
Kaveh Baghaei, Sogol Mazhari, Samaneh Tokhanbigli, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 4, pp. 1044-1061
Closed Access | Times Cited: 51
A novel A2a adenosine receptor inhibitor effectively mitigates hepatic fibrosis in a metabolic dysfunction-associated steatohepatitis mouse model
Seojeong Park, Seohui Hwang, Jingyang Sun, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 5, pp. 1855-1870
Open Access | Times Cited: 7
Quercetin ameliorates thioacetamide‐induced hepatic fibrosis and oxidative stress by antagonizing the Hedgehog signaling pathway
Andleeb Aslam, Nadeem Sheikh, Muhammad Shahzad, et al.
Journal of Cellular Biochemistry (2022) Vol. 123, Iss. 8, pp. 1356-1365
Closed Access | Times Cited: 24
The Potential Application of Magnetic Nanoparticles for Liver Fibrosis Theranostics
Aziz Eftekhari, Allahveirdy Arjmand, Ayyub Asheghvatan, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 28
Compensated liver cirrhosis: Natural course and disease-modifying strategies
Ramesh Kumar, Sudhir Kumar, Sabbu Surya Prakash
World Journal of Methodology (2023) Vol. 13, Iss. 4, pp. 179-193
Open Access | Times Cited: 11
Inhibition of 11β-hydroxysteroid dehydrogenase 1 relieves fibrosis through depolarizing of hepatic stellate cell in NASH
Su‐Yeon Lee, Sanghwa Kim, Inhee Choi, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 18
A near-infrared fluorescent probe for differentiating cancer cells from normal cells and early diagnosis of liver cirrhosis
Chenyuan Long, Qingqing Ma, Ling Huang, et al.
Analytica Chimica Acta (2024) Vol. 1316, pp. 342802-342802
Closed Access | Times Cited: 3
Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis
Chien–Yu Lin, Pratik Adhikary, Kun Cheng
Advanced Drug Delivery Reviews (2021) Vol. 174, pp. 127-139
Open Access | Times Cited: 22
IGF2-NR4A2 Signaling Regulates Macrophage Subtypes to Attenuate Liver Cirrhosis
Lichao Yao, Xue Hu, Mengqin Yuan, et al.
Journal of Clinical and Translational Hepatology (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 8
The Role of the Gastrointestinal Microbiome in Liver Disease
Nicholas Shalaby, Dorit Samocha‐Bonet, Nadeem O. Kaakoush, et al.
Pathogens (2023) Vol. 12, Iss. 9, pp. 1087-1087
Open Access | Times Cited: 6
Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis
Daniel Sepúlveda‐Crespo, Salvador Resino, Isidoro Martínez
Drugs (2021) Vol. 81, Iss. 4, pp. 419-443
Closed Access | Times Cited: 15
Relaxin in hepatic fibrosis: What is known and where to head?
Devaraj Ezhilarasan
Biochimie (2021) Vol. 187, pp. 144-151
Closed Access | Times Cited: 15
Identification of hepatic fibrosis inhibitors through morphometry analysis of a hepatic multicellular spheroids model
Yeonhwa Song, Sanghwa Kim, Jinyeong Heo, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 14
The hepatoprotective effects of the polyphenol-enriched n-butanol fraction of Cnicus benedictus against carbon tetrachloride-induced liver fibrosis in rats: In vivo study
Mohammed Jasim Mohammed, Haitham Mahmood Kadhim
Toxicology Reports (2024) Vol. 14, pp. 101850-101850
Open Access | Times Cited: 1
Antifibrotic effect of curcumin, N-acetyl cysteine and propolis extract against bisphenol A-induced hepatotoxicity in rats: Prophylaxis versus co-treatment
Sahar E. El-Swefy, Fatma Rizk Abdallah, Alaa S. Wahba, et al.
Life Sciences (2020) Vol. 260, pp. 118245-118245
Closed Access | Times Cited: 12
Progress and Challenges in the Use of a Liver-on-a-Chip for Hepatotropic Infectious Diseases
Kasem Kulkeaw, Worakamol Pengsart
Micromachines (2021) Vol. 12, Iss. 7, pp. 842-842
Open Access | Times Cited: 11
P-element-Induced Wimpy-Testis-Like Protein 1 Regulates the Activation of Pancreatic Stellate Cells Through the PI3K/AKT/mTOR Signaling Pathway
Ran Xue, Jun Zhou, Jing Wu, et al.
Digestive Diseases and Sciences (2022) Vol. 68, Iss. 4, pp. 1339-1350
Closed Access | Times Cited: 7
A Paradigm Shift in Primary Liver Cancer Therapy Utilizing Genomics, Molecular Biomarkers, and Artificial Intelligence
James Moroney, Juan Trivella, Ben George, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2791-2791
Open Access | Times Cited: 3
Establishment of a Rat Model of Liver Venous Deprivation: Simultaneous Portal and Hepatic Vein Ligation
Yuefeng Zhang, Xiaoqin He, Peng Ma, et al.
Journal of Clinical and Translational Hepatology (2022) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 5
Conformationally Restricted Dipeptide-Based Nanoparticles for Delivery of siRNA in Experimental Liver Cirrhosis
Saikat Biswas, Nitin Yadav, Pinky Juneja, et al.
ACS Omega (2022) Vol. 7, Iss. 41, pp. 36811-36824
Open Access | Times Cited: 5
Exosomes of Whartons' jelly mesenchymal stem cell reduce the NOX genes in TGF-β-induced hepatic fibrosis.
Reza Afarin, Tahereh Behdarvand, Elham Shakerian, et al.
DOAJ (DOAJ: Directory of Open Access Journals) (2022) Vol. 25, Iss. 12, pp. 1498-1503
Closed Access | Times Cited: 5
Preclinical Models and Promising Pharmacotherapeutic Strategies in Liver Fibrosis: An Update
Tea Omanović Kolarić, Lucija Kuna, Marina Čović, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 5, pp. 4246-4260
Open Access | Times Cited: 2
Knockdown of TRIM15 inhibits the activation of hepatic stellate cells
Junpei Zhang, Yin Chen, Yi Tian, et al.
Journal of Molecular Histology (2021) Vol. 52, Iss. 4, pp. 839-848
Closed Access | Times Cited: 5
The Interface of Gene Editing with Regenerative Medicine
Veronica E. Farag, Elsie A. Devey, Kam W. Leong
Engineering (2024)
Open Access
Page 1 - Next Page

Scroll to top